PANITUMUMAB for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 43 adverse event reports in the FDA FAERS database where PANITUMUMAB was used for Off label use.
Most Reported Side Effects for PANITUMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 1,392 | 12.8% | 121 | 291 |
| Diarrhoea | 1,123 | 10.3% | 146 | 413 |
| Death | 767 | 7.1% | 767 | 127 |
| Dermatitis acneiform | 758 | 7.0% | 71 | 167 |
| Neutropenia | 757 | 7.0% | 84 | 112 |
| Skin toxicity | 728 | 6.7% | 38 | 59 |
| Neuropathy peripheral | 613 | 5.6% | 45 | 67 |
| Hypomagnesaemia | 611 | 5.6% | 63 | 117 |
| Nausea | 608 | 5.6% | 88 | 174 |
| Disease progression | 600 | 5.5% | 155 | 67 |
| Colorectal cancer metastatic | 583 | 5.4% | 182 | 87 |
| Off label use | 563 | 5.2% | 103 | 98 |
| Fatigue | 505 | 4.6% | 67 | 131 |
| Thrombocytopenia | 480 | 4.4% | 61 | 119 |
| Paronychia | 443 | 4.1% | 38 | 107 |
Other Indications for PANITUMUMAB
Colorectal cancer metastatic (3,420)
Product used for unknown indication (1,810)
Colon cancer (1,726)
Colorectal cancer (878)
Adenocarcinoma of colon (610)
Colon cancer metastatic (398)
Metastases to liver (391)
Rectal cancer (374)
Rectal adenocarcinoma (195)
Rectal cancer metastatic (145)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)